𝔖 Bobbio Scriptorium
✦   LIBER   ✦

T1138 Global Safety of Adalimumab in Crohn's Disease Clinical Trials

✍ Scribed by Colombel, Jean-Frédéric; Panaccione, Remo; Sandborn, William J.; Rutgeerts, Paul; Hanauer, Stephen B.; Reinisch, Walter; Pollack, Paul F.; Kent, Jeffrey D.; Cardoso, Alexandra T.; Lau, Winnie


Book ID
123404105
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
203 KB
Volume
134
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Adalimumab safety in global clinical tri
✍ Jean-Frédéric Colombel; William J. Sandborn; Remo Panaccione; Anne M. Robinson; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

Background: Adalimumab, a fully human anti-tumor necrosis factor (anti-TNF) monoclonal antibody, is approved for the treatment of Crohn's disease (CD) in adults. We evaluated the overall safety profile of adalimumab in global clinical trials in patients with CD. Patients who participated in these tr